This policy addresses the coverage for tumor markers only when utilized for the management of cancerous conditions. Tumor marker
![Tumor Markers in Pancreatic Cancer: A Comparative Clinical Study between CEA, CA 19-9 and CA 50 | Semantic Scholar Tumor Markers in Pancreatic Cancer: A Comparative Clinical Study between CEA, CA 19-9 and CA 50 | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f005295af4f24478cf0440a16a86437c025b6c6e/4-TableII-1.png)
Tumor Markers in Pancreatic Cancer: A Comparative Clinical Study between CEA, CA 19-9 and CA 50 | Semantic Scholar
Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases. - Abstract - Europe PMC
![Tumor Markers in Pancreatic Cancer: A Comparative Clinical Study between CEA, CA 19-9 and CA 50 | Semantic Scholar Tumor Markers in Pancreatic Cancer: A Comparative Clinical Study between CEA, CA 19-9 and CA 50 | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f005295af4f24478cf0440a16a86437c025b6c6e/4-Table11-1.png)